Allsup, D;
Howard, D;
Emmerson, J;
Hockaday, A;
Rawstron, A;
Oughton, JB;
Bloor, A;
... Hillmen, P; + view all
(2021)
COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study.
British Journal of Haematology
, 194
(3)
pp. 646-650.
10.1111/bjh.17526.
Preview |
PDF
10421_COSMIC_BJHlet_main_V2.pdf - Accepted Version Download (202kB) | Preview |
| Type: | Article |
|---|---|
| Title: | COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1111/bjh.17526 |
| Publisher version: | https://doi.org/10.1111/bjh.17526 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | chemotherapy, chronic lymphocytic leukaemia, clinical trial, minimal residual disease, monoclonal antibody, Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bendamustine Hydrochloride, Cyclophosphamide, Female, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Male, Middle Aged, Treatment Outcome, Vidarabine |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10212952 |
Archive Staff Only
 |
View Item |
